Bacopa monnieri für Age-Related Cognitive Decline

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dbacopa\u002Dmonnieri\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Fazit

Key Study Findings

Randomized Controlled Trial 6 weeks Double-blind

Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in …

Dose: 120 mL twice daily for 45 days vs.: placebo Outcome: telomerase activity and telomere length Wirkung: None None

Population: elderly participants with MoCA score >=24

Randomized Controlled Trial n=76 12 weeks Double-blind

Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients …

Dose: 300 mg/day standardized Bacopa monnieri extract vs.: placebo Outcome: change in composite z score of memory at … Wirkung: None None

Population: patients with amnestic mild cognitive impairment, mean age 62.2 years, 88.3% men

Other

Differential Alterations in the Expression of AMPA Receptor and Its Trafficking Proteins in the Hippocampus …

Dose: 200 mg/kg body weight vs.: Rotenone-PD mice without BME Outcome: Recognition memory and AMPA receptor expression Wirkung: None None

Population: Rotenone-induced Parkinson's disease mouse model

Systematic Review

Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review.

Dose: None vs.: None Outcome: Cholinesterase inhibition and cognitive improvement Wirkung: None None

Population: In vivo animal models of AD

Other

A systems biology approach reveals dual neurotherapeutic mechanisms of Dioscorea bulbifera in Alzheimer's disease via …

Dose: None vs.: Donepezil, Estradiol Outcome: Neurotherapeutic activity via ESR1 and ACHE Wirkung: None None

Population: In silico AD modeling (systems biology)

Systematic Review n=1861

The effect of plant active substances on cognitive function in healthy older adults: a systematic …

Dose: None vs.: Placebo or no intervention Outcome: Cognitive function (learning, memory, executive) Wirkung: Raisin SUCRA 95.1%; tart cherry 89.5% for memory None

Population: Healthy older adults

Key Statistics

Studien

1200

Teilnehmer

↑

Positive

Bewertung

Referenced Papers

Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (Prakriti) in … Other

Frontiers in medicine 2026

Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment … Other

JMIR research protocols 2026

Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review. Review

Brain sciences 2025 14 Zitierungen

A systems biology approach reveals dual neurotherapeutic mechanisms of Dioscorea bulbifera in Alzheimer's disease via estrogen signaling and cholinergic modulation. Other

Inflammopharmacology 2025 4 Zitierungen

Differential Alterations in the Expression of AMPA Receptor and Its Trafficking Proteins in the Hippocampus Are Associated with Recognition Memory … Other

Molecular neurobiology 2025 3 Zitierungen

The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of … Systematic Review

Frontiers in pharmacology 2025

Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration. Review

Current Alzheimer research 2024 10 Zitierungen

A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with … Systematic Review

Systematic reviews 2023 10 Zitierungen

Levetiracetam exposure during prenatal and postnatal period induces cognitive decline in rat offsprings, not completely prevented by Bacopa monnieri. Other

Journal of complementary … 2022 3 Zitierungen

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Review

Journal of clinical … 2021 38 Zitierungen

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. Systematic Review

Journal of alternative … 2021 13 Zitierungen

Online Promotion of "Brain Health" Supplements. Other

The Senior care … 2021 2 Zitierungen

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. Other

Alzheimer's research & … 2021 1 Zitierungen

Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical … Review

Drug target insights 2019 103 Zitierungen

Botanicals and phytochemicals active on cognitive decline: The clinical evidence. Review

Pharmacological research 2018 67 Zitierungen

Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A … RCT

The journal of … 2017 30 Zitierungen

Cognitive training and Bacopa monnieri: Evidence for a combined intervention to alleviate age associated cognitive decline. Other

Medical hypotheses 2016 6 Zitierungen

Bacopa monnieri as an Antioxidant Therapy to Reduce Oxidative Stress in the Aging Brain. Review

Evidence-based complementary and … 2015 82 Zitierungen

Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product. RCT

Clinical drug investigation 2014 54 Zitierungen

Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. Review

CNS drugs 2013 138 Zitierungen

Neuroprotective effects of Bacopa monnieri in experimental model of dementia. Other

Neurochemical research 2012 85 Zitierungen

A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning … RCT

Nutrition journal 2012 55 Zitierungen

A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Review

Alternative medicine review … 1999 112 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:: 300-600 mg/day standardized to 50% bacosides
memorysupport:: 300 mg/day for minimum 8-12 weeks

Obergrenze: Not established; well-tolerated up to 600 mg/day in trials

In der Forschung untersuchte Dosierungen

Dosierung	Dauer	Wirkung	N
120 mL twice daily for 45 days	6 weeks	Neutral	--
300 mg/day standardized Bacopa monnieri extract	12 weeks	Neutral	76
200 mg/kg body weight	--	Positive	--
None	--	Positive	--
None	--	Positive	--
None	--	Positive	1861
None	--	Mixed	--
None	12 weeks	Positive	--

Beste Einnahmezeit: With meals; effects require 8-12 weeks of consistent use

Safety & Side Effects

Gemeldete Nebenwirkungen

⚠ Gastrointestinal discomfort (nausea, cramping, diarrhea)
⚠ Dry mouth
⚠ Fatigue in some individuals
⚠ Mild sedation at higher doses

Bekannte Wechselwirkungen

● Thyroid medications (may increase thyroid hormone levels)
● Anticholinergic drugs (opposes cholinergic enhancement)
● Sedative medications (additive CNS depression)
● Calcium channel blockers (may enhance blood pressure lowering)

Tolerierbare Höchstaufnahmemenge: Not established; well-tolerated up to 600 mg/day in trials

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Bacopa monnieri help with Age-Related Cognitive Decline?

Based on 15 studies with 1,200 participants, there is moderate evidence from clinical studies that Bacopa monnieri may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).

How much Bacopa monnieri should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 300-600 mg/day standardized to 50% bacosides. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Bacopa monnieri?

Reported side effects may include Gastrointestinal discomfort (nausea, cramping, diarrhea), Dry mouth, Fatigue in some individuals, Mild sedation at higher doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Bacopa monnieri and Age-Related Cognitive Decline?

We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 1,200 total participants. The overall direction of effect is positive.

Related Evidence

Andere Inhaltsstoffe für Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) A Phosphatidylserine B Vitamin B12 B Curcumin B Ginkgo biloba C Panax Ginseng C

Bacopa monnieri für andere Beschwerden

Memory Loss A Attention & Focus Difficulties C

Kurzfazit

Evidence Strength72%

High confidence

Studienübersicht

RCT (3)Meta (0)Other (12)

Alternativen vergleichen

Sehen Sie, wie andere Inhaltsstoffe bei dieser Beschwerde abschneiden.

Alle Inhaltsstoffe ansehen für Age-Related Cognitive Decline

Mehr erfahren

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.